 |
MYELOMA
CANADA NEWS
October 2016
|
HIGHLIGHTS FROM THE MYELOMA CANADA SCIENTIFIC ROUNDTABLE CONFERENCE
On September 16 and 17, Myeloma Canada hosted the 7
th annual Myeloma Canada Scientific Roundtable in Montreal. Co-chaired by Dr Tony Reiman from Saint John and Dr Chris Venner from Edmonton, the meeting brought together over 80 stakeholders, including Canada's top myeloma experts from coast to coast, scientists from the USA and Europe, our industry research partners and patients. This year's guest speakers included Dr Ola Landgren from Memorial Sloan Kettering Cancer Center in New York; Dr Antonio Palumbo; Dr Marta Chesi and Dr Leif Bergsagel from the Mayo Clinic in Scottsdale; Dr Noemi Puig from University Hospital in Salamanca, Spain; Dr David Murray from the Mayo Clinic in Rochester; Dr Jonathan Keats from the Translational Genomics Research Institute; and Dr Don Morris, this year's recipient of the Myeloma Canada/Cancer Research Society Research Grant, from the Tom Baker Cancer Centre in Calgary.
A wide range of current topics in myeloma research were discussed, including minimal residual disease (MRD), genomics, cell therapy, oncolytic viral therapy and individualization of myeloma therapy using risk stratification models.
Additionally, clinical trial ideas incorporating innovative immuno-oncology strategies were discussed resulting in three new MCRN clinical trials that will be further developed.
The meeting is an incubator for clinical trial ideas and supports our goal of developing high-impact made-in-Canada clinical trials for patients across the country. The conference was a huge success, with each year proving to be better than the last. The highly valuable presentations and topics sparked important discussions, the sharing of ideas and a forward-thinking thought processes. All in all the event invoked a positive sense of motivation and collaboration amongst all who attended. Next year's Scientific Roundtable, to be co-chaired by Dr Jonathan Keats and Dr Victor Zepeda, is scheduled for September 15 and 16 in Montreal.
|
MYELOMA CANADA LAUNCHES A NEW SUPPORT PROGRAM FOR PATIENTS AND THEIR CAREGIVERS
You've spoken and Myeloma Canada has listened! We are excited to announce the launch of a new initiative that will provide helpful advice to myeloma patients and their caregivers. This new program, which is available to all patients, whether newly-diagnosed or long-term survivors, is intended to help better navigate the health care system and other services.
Read more...
|
WE'RE TAKING ACTION TO INCREASE AWARENESS
|
|
|
Martine Elias, Director of Access, Advocacy and Community Relations at Myeloma Canada
|
PUTTING MULTIPLE MYELOMA ON THE MAP
Learn more how Myeloma Canada is making myeloma matter and increasing awareness across the country, by
clicking here
|
AN UPDATE ON THE MCRN CLINICAL TRIAL RESEARCH
The Myeloma Canada Research Network is currently focused on Phase I and Phase II clinical trials with an emphasis on developing trials based on research ideas proposed by members of the network across Canada. Learn more about our active clinical trials and recruiting centres by
clicking here
|
MYELOMA CANADA RESEARCH NETWORK (MCRN) ANNOUNCES BOARD OF DIRECTORS
Earlier this year, the MCRN was established as a separate non-profit organization to better focus on the pursuit of its mission.
Embodying the spirit of collaboration through a pan-Canadian perspective, the MCRN Board of Directors reflects both the diversity and unity of purpose of the Canadian myeloma community.
Read More...
|
WHAT'S HAPPENING IN THE COMMUNITY
|
|
 |
|
2
016 Multiple Myeloma March, Montreal
|
|
To learn more about what's happening your community and view the early results and pictures from the 2016 Multiple Myeloma March,
|
WE HAVE OFFICIALLY EXCEEDED OUR GOAL FOR THE
2016 MULTIPLE MYELOMA MARCH !
The 2016 Multiple Myeloma March is now behind us and, by all accounts, it was a major success!
The overwhelming achievement of this year's March is thanks to the hundreds of people who participated across Canada: the sponsors, the volunteers, the donors, the patients, the caregivers, their families and friends, and the healthcare professionals.
We would like to extend a heartfelt thank you to the individuals behind the Calgary, Enderby, Greater Toronto Area, Halifax, Kelowna, Melville, Montreal, Ottawa-Gatineau, Quebec City, Sault Ste. Marie, Windsor/Essex-County and Winnipeg multiple myeloma communities for Walking the Walk and Making Myeloma Matter. Your dedication helped raise awareness and put myeloma on the map.
We are proud to announce that we have officially surpassed our fundraising goal of $500,000! To date, we have achieved
$504,210.02
Congratulations once again for walking the walk, and making myeloma matter!
The Multiple Myeloma March has a unique way of bringing people together to strengthen the voice Canadian myeloma community. Learn how we are making a difference by increasing awareness and raising funds for Canadian research by viewing the video below.
As we bring the event to a close for this year, remember it's not too late to donate. The Multiple Myeloma March website will continue to accept donations until the end of the year.
|
|
| |
|
|
|
|
